全球牙科生物材料市場-2022-2029

市場動態

牙科疾病患病率上升、老年人口不斷增長、對美容牙科的需求不斷增加、牙科和口腔護理支出增加、採用新型粘合劑、CAD/CAM 中的樹脂粘固劑和其他數字技術在

預計口腔疾病的增長將推動市場增長。

牙周病、蛀牙、口腔癌、齲齒和口臭等口腔疾病正在推動市場增長。根據美國疾病控制和預防中心 (CDC) 的數據，在 46% 的 30 歲以上人群中發現了牙周病的跡象，嚴重牙周病影響約 9% 的成年人。此外，未經治療的蛀牙影響了美國約 26% 的人。此外，根據美國國立牙科和顱面研究所的數據，92% 的 20 至 64 歲的成年人的恆牙有蛀牙，平均嚴重程度為 3.28 個蛀牙和 13.65 顆恆牙缺失，據說有。提高對中低收入國家牙科植入物重要性的認識預計將推動整個預測期內的市場增長。此外，隨著發達國家可支配收入的增加，對牙齒美白和牙齦輪廓等美容程序的需求也在增加。因此，從上述陳述來看，預計市場將在預測期內受到驅動。

約束

高昂的治療成本、嚴格的法規和臨床流程以及低保險報銷將在預測期內抑制市場。

行業分析

牙科生物材料市場根據各種行業因素（包括未滿足的需求、定價分析、供應鏈分析和監管分析）對市場進行深入分析。

內容

第一章研究方法與範圍

• 調查方法
• 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

• 按產品劃分的市場細分
• 按類型劃分的市場細分
• 按應用劃分的市場細分
• 最終用戶的市場細分
• 按地區劃分的市場細分
• DataM CLO 場景

第 4 章市場動態

• 市場影響因素
  • 驅動程序
    • 牙科疾病的患病率增加
    • 不斷增長的老年人口
    • 牙科費用增加
    • 技術進步
  • 限制因素
    • 治療費用高
    • 嚴格的監管和臨床流程
  • 商機
  • 影響分析

第五章行業分析

• 波特五力分析
• 供應鏈分析
• 監管分析
• 流行病學

第 6 章按產品分類

• 骨移植材料
  • 沿著嫁接
  • 異種移植
  • 合成樹脂
• 牙膜
• 軟組織再生材料
• 其他（牙科粘固劑、牙科印模材料）

第 7 章按類型

• 金屬
• 陶瓷
• 天然牙科生物材料

第 8 章按應用程序

• 種植體領域
• 牙周病學
• 牙科修復
• 正畸
• 其他

第 9 章，最終用戶

• 種植牙和假牙製造商
• 牙科實驗室
• 牙科醫院/牙科診所
• 其他（牙科學院、研究所等）

第 10 章按地區劃分

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 意大利
  • 西班牙
  • 其他歐洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 其他亞太地區
• 中東和非洲

第 11 章競爭格局

• 競爭場景
• 競爭性牙科生物材料戰略分析
• 比較產品組合分析
• 市場情況/份額分析
• 併購分析

第 12 章公司簡介

• Straumann AG
  • 公司概況
  • 產品組合和描述
  • 主要亮點
  • 財務摘要
• Geistlich Pharma AG
• Zimmer Biomet Holdings, Inc.
• Danaher Corporation
• Dentsply Sirona, Inc.
• 3M Company
• Royal DSM
• Kuraray Co., Ltd
• Medtronic Plc.
• Henry Schein, Inc.
• Victrex Plc
• Ivoclar Vivadent AG
• BEGO Medical GmbH

第13章 DataM

Market Overview

The Dental Biomaterials Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.7% during the forecast period (2022-2029)

Dental biomaterials are specialized natural or synthetic products designed to be used in preventive and restorative dentistry. These products are used to restore damaged, decayed, or fractured teeth. Dental biomaterials are efficient products with a high success rate in oral treatment and prevention. These products replace the damaged or missing tooth tissues and also promote tissue regeneration. Natural biomaterials include enamel, dentin, cementum, bone, and other intraoral tissues and synthetic materials include metals, ceramics, polymers, and composite structures.

Market Dynamics

The market is driven by the growing prevalence of dental disorders, rising geriatric population, increasing demand for cosmetic dentistry, increase in expenditure on dental and oral care, and increasing adoption of novel adhesives, resin cement in CAD/CAM, and other digital technologies.

The increasing prevalence of oral disorders is expected to drive market growth.

Oral disorders such as periodontal disease, tooth decay, oral cancer, dental caries, and halitosis, among others, are driving the market growth. According to the Centers for Disease Control and Prevention (CDC), indications of gum disease are present in 46 percent of all persons aged 30 and older, with serious gum disease affecting approximately 9% of adults. Untreated dental decay affects approximately 26% of persons in the United States. Furthermore, according to the National Institute of Dental and Craniofacial Research, 92 percent of adults aged 20 to 64 have dental caries in their permanent teeth, with an average severity of 3.28 decayed or missing permanent teeth and 13.65 decaying and missing permanent teeth. Increased awareness of the significance of dental implants in middle and low-income nations will drive market growth throughout the forecast period. Aside from that, as disposable income in industrialized countries has increased, so has demand for aesthetic procedures like teeth whitening and gum contouring. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

High cost of treatment, presence of stringent regulatory and clinical processes, and low reimbursement coverage by insurance are going to restrain the market in the forecast period.

Industry Analysis

The dental biomaterials market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

Polymeric Biomaterials segment is expected to hold the largest market share in the dental biomaterials market.

The polymeric biomaterials segment accounted for the largest market share in 2021. The segment benefits because of high product durability, reduced risks of infections compared to other materials, material flexibility that provides ease in shape formation, biocompatibility, good resilience, lightweight, easy fabrication, and high corrosion resistance. Moreover, polymeric biomaterials have unique antimicrobial and drug delivery properties in preventive, regenerative, and restorative therapies to reduce friction and corrosion in dentistry. Therefore, it has increased the demand for polymeric biomaterials. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global dental biomaterials market.

The North American region accounted for the largest market share in 2021. Owing to the increasing prevalence of caries and the presence of major players within the region, high dental expenditure within the Americas are the factors to drive the market growth. For instance, according to a recent paper by the American College of Prosthodontists, more than 36 million Americans are toothless, and 120 million have at least one missing tooth. Such circumstances in the Americas increase the demand for prosthodontics and implants. Moreover, Pulpdent Corporation, a dental research and manufacturing business in the Greater Boston area, launched ACTIVA Presto dental material in January 2020. The new white dental filling material has qualities similar to natural teeth. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the dental biomaterials market are Straumann AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Kuraray Co., Ltd, Medtronic Plc., Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex Plc, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd, BEGO Medical GmbH, Cam Bioceramics B.V., Geistlich Pharma AG, BioHorizons IPH, Inc., and Biomatlante.

Straumann:

Straumann is a global leader in implant, restorative and regenerative dentistry. The company researches, develop, and manufacture dental implants, instruments, prosthetics, and tissue and bone regeneration biomaterials in collaboration with leading clinics, research institutes, and universities for tooth replacement and restoration or to prevent tooth loss. The company has six production sites for implants, biomaterials and CAD/CAM in Europe, the United States and Japan. Its extensive network of distribution subsidiaries and partners makes its products and services available in over 70 countries. The company's periodontal product portfolio includes Straumann Emdogain FL, leading to true periodontal regeneration based on biomimicry.

Product Portfolio:

Straumann XenoFlex: Straumann XenoFlex is a biomimetric composite material that resembles the native bone in its basic biphasic composition of collagen and xenogenic hydroxyapatite. It has beneficial handling characteristics and the ability to be shaped to match the individual defect situation. Straumann XenoFlex - an efficient, easy to handle, volume stable solution for the treatment of bone defects.

The global dental biomaterials market report would provide an access to an approx. 45+market data table, 40+figures

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Type
• 3.3. Market Snippet by Application
• 3.4. Market Snippet by End User
• 3.5. Market Snippet by Region
• 3.6. DataM CLO Scenario

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing prevalence of dental disorders
    • 4.1.1.2. Rising geriatric population
    • 4.1.1.3. Increase in expenditure on dental
    • 4.1.1.4. Technological advancements
  • 4.1.2. Restraints
    • 4.1.2.1. High cost of treatment
    • 4.1.2.2. Stringent regulatory and clinical processes
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis
• 5.4. Epidemiology

6. By Product

• 6.1. Introduction
• 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
• 6.3. Market Attractiveness Index, By Product
• 6.4. Bone Graft Materials*
  • 6.4.1. Introduction
  • 6.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.4.3. Allografts
  • 6.4.4. Xenografts
  • 6.4.5. Synthetic
• 6.5. Dental Membranes
• 6.6. Soft Tissue Regeneration Products
• 6.7. Others (dental cement, dental impression materials)

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Metallic
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
• 7.3. Ceramic
• 7.4. Natural Dental Biomaterials

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Implantology
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
• 8.3. Periodontology
• 8.4. Prosthodontics
• 8.5. Orthodontics
• 8.6. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Dental implant and prosthetic manufacturers
  • 9.4.1. Introduction
  • 9.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
• 9.3. Dental laboratories
• 9.4. Dental hospitals and clinics
• 9.5. Others (Dental academies and research institutes)

10. By Region

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Mexico
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. South America
  • 10.3.1. Brazil
  • 10.3.2. Argentina
  • 10.3.3. Rest of South America
• 10.4. Asia Pacific
  • 10.4.1. China
  • 10.4.2. India
  • 10.4.3. Japan
  • 10.4.4. Australia
  • 10.4.5. Rest of Asia Pacific
• 10.5. Middle East and Africa

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Competitor Dental Biomaterials Strategy Analysis
• 11.3. Comparative Product Portfolio Analysis
• 11.4. Market Positioning/Share Analysis
• 11.5. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Straumann AG*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Geistlich Pharma AG
• 12.3. Zimmer Biomet Holdings, Inc.
• 12.4. Danaher Corporation
• 12.5. Dentsply Sirona, Inc.
• 12.6. 3M Company
• 12.7. Royal DSM
• 12.8. Kuraray Co., Ltd
• 12.9. Medtronic Plc.
• 12.10. Henry Schein, Inc.
• 12.11. Victrex Plc
• 12.12. Ivoclar Vivadent AG
• 12.13. BEGO Medical GmbH

13. DataM Intelligence

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3 Contact Us